Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Universitat Autònoma de Barcelona](/img/noimage_org.png)
Universitat Autònoma de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat Autònoma de Barcelona (10)
2024
-
Expert Consensus Recommendations for the Management of Ocular Surface Inflammation in Patients with Glaucoma
Journal of Glaucoma
-
PreserfloTM MicroShunt implantation combined with OlogenTM in primary and secondary glaucoma patients in a clinical setting
Indian Journal of Ophthalmology, Vol. 72, Núm. 3, pp. 417-426
2022
-
Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Drug Delivery, Vol. 29, Núm. 1, pp. 2357-2374
2021
-
Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging
Biomedicines, Vol. 9, Núm. 12
-
Chronic glaucoma using biodegradable microspheres to induce intraocular pressure elevation. Six-month follow-up
Biomedicines, Vol. 9, Núm. 6
-
Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
Drug Delivery, Vol. 28, Núm. 1, pp. 2427-2446
-
Novel use of plga microspheres to create an animal model of glaucoma with progressive neuroretinal degeneration
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20
2020
-
Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema
Frontiers in Immunology, Vol. 11
2019
-
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
PLoS ONE, Vol. 14, Núm. 1